This site is for health care professionals only.

@ ESMO Virtual Congress 2020

 

Reimagining Breast Cancer: Transforming Treatment for Breast Cancer Patients

Breast Cancer Disease Education Library

Kaleidoscope image of older women’s faces with PIK3CA overlapping

The PIK3CA Mutation Matters

Learn More

The invisible woman report

The Invisible Woman 2.0

artivism

ARTIVISM

Learn More

Clinical Trials

NATALEE
BYLieve
LAG525 Plus Spartalizumab in Advanced Triple-Negative Breast Cancer
EPIK-B2
EPIK-B3

Compound Cards

PI3Kα inhibitor: Alpelisib (BYL719)
LAG-3 monoclonal antibody: leramilimab (LAG525)
PD-1 monoclonal antibody: Spartalizumab (PDR001)
All compounds are either investigational or being studied for (a) new uses(s). Efficacy and safety have not been established. There is no guarantee that they will become commercially available for the use(s) under investigation.